Glucocorticoids, antioxidants and staurosporine modulate the adherence between monocytes and malaria infected erythrocytes

Inflammation Research

Volumn 48, Issue 12, 1999, Pages 657-661

  Goldring, J P D ^a   Ramoshebi, L N ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Antiinflammatory; Antioxidant; Immunomodulation; Malaria; Monocyte adherence

Indexed keywords

AMBROXOL; DANAZOL; DEXAMETHASONE; HYDROCORTISONE; PROBUCOL; STAUROSPORINE;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ERYTHROCYTE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; INFECTION RESISTANCE; MALARIA; MONOCYTE;

EID: 0033390840     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050518     Document Type: Article

References (47)

1. [1] Sadick, MD. Macrophages in parasitic infection. In: Lewis CE, McGee J O'D, editors. The Macrophage: The Natural Immune System. Oxford: IRL, 1992: 265 - 84.
2. [2] Asch C. Macrophages at the centre of infection. Parasitol Today 1991; 7: 2-3.
3. [3] Goldring JPD, Molyneux ME, Taylor TE, Wirima JJ, Hommel M. Plasmodium falciparum: diversity of strains from Malawi in their cytoadherence to melanoma cells and monocytes in vitro. Br J Haematol 1992; 81: 413-8.
4. [4] Goldring JPD, Hommel M. Variation in the cytoadherence characteristics of malaria parasites: is this a true virulence factor? Mem Inst Oswaldo Cruz 1992; 87: 313-22.
5. [5] Waage A, Slupphaug G, Shalaby R. Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol 1990; 20: 4239-43.
6. [6] Breuninger LM, Dempsey WL, Uhl J, Murasko DM. Hydrocortisone regulation of interelukin-6 protein production by a purified population of human peripheral blood monocytes. Clin Immunol Immunopathol 1993; 69: 205-14.
7. [7] Lew W, Oppenheim JJ, Matsushime K. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone J Immunol 1988; 140: 1895-1902.
8. [8] Morikawa K, Watabe H, Araake M, Morikawa S. Modulatory effects of antibiotics on cytokine production by human monocyte in vitro. Antimicrob. Agents Chemother 1996; 40: 1366-70.
9. [9] Beutler B, Cerami A. The common mediator of shock cachexia and tumour necrosis. Adv Immunol 1982; 42: 213-31.
10. [10] Rinehart KJ, Kevile L, Clayton S, Figueroa JA. Corticosteroids alter hematopoeisis in vitro by enhancing human monocyte secretion of granulocyte-colony-stimulating factor. Exp Haematol 1997; 25: 405-12.
11. [11] Li SR, Forster L, Anggard El, Ferns G. The effects of LPS and probucol on interleukin 1 and platelet-derived growth factor gene expression in the human monocyte cell line U 937. Biochem Biophys Acta 1994; 1225: 271-4.
12. [12] Bianchi M, Mantovani A, Erroi A, Dinarello CA, Ghezzi P. Ambroxol inhibits interleukin 1 and tumour necrosis factor production in human monocytes. Agents Actions 1990; 31: 275-9.
13. [13] Mori H, Nakagawa M, Itoh N, Wada K, Tanaya T. Danazol suppresses the production of interleukin 1 beta and tumour necrosis factor by human monocytes. Am J Reprod Immunol 1990; 24: 45-50.
14. [14] Gibbs BF, Schmutzler W, Vollrath B, Brostardt P, Braam U, Wolf HH, et al. Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflamm Res 1999; 48: 86-93.
15. [15] Tailor A, Das AM, Getting SJ, Flower RJ, Perretti M. Subacute treatment of rats with dexamethasone reduces ICAM-1 levels on circulating monocytes. Biochem Biophys Res Commun 1997; 231: 675-8.
16. [16] Yesner LM, Huh HY, Perace SF, Siverstein RL. Regulation of monocyte CD36 and thrombospondin expression by soluble mediators. Arterioscler Thromb Vase Biol 1996; 16: 1019-25.
17. [17] Kaneko M, Hayashi J, Saito I, Miyasaka N. Probucol down-regulates E-selectin on cultured human vascular endothelial cells. Arterioscler Thromb Vase Biol 1996; 16: 1047-51.
18. [18] Ferns GAA, Forster L, Stewertlee A, Nouroozzadeh J, Anggard EE. Probucol inhibits mononuclear cell-adhesion to vascular endothelium in the cholesterol-fed rabbit. Atherosclerosis 1993; 100: 171-81.
19. [19] Ota II, Igarashi SD, Hayakawa M, Matsui T, Tanaka H, Tanaka T. Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis - a multi-center cooperative study. Fertil Steril 1996; 65: 545-51.
20. [20] Sackstein R, Borenstein M. The effects of corticosteroids on lymphocyte recirculation in humans - analysis of the mechanism of impaired lymphocyte migration to lymph-node following methylprednisolone administration. J Investig Med 1995; 43: 68-77.
21. [21] Gillissen A, Bartling A, Schoen S, Schultzewerninghaus G. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung 1997; 175: 235-42.
22. [22] Neuner P, Klosner G, Schauer E, Pourmojib M, Macheiner W, Grunwald C, et al. Pentoxifylline in vivo downregulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor alpha by human blood peripheral mononuclear cells. Immunology 1994; 83: 262-7.
23. [23] Nakamura H, Haley KJ, Nakamura T, Luster AD, Lilly CM. Differential regulation of eotaxin expression by TNF alpha and PMA in human monocytic U-937 cells. Am J Physiol 1998; 19: L601 10.
24. [24] Ritzenthaler J, Roman J. Differential effects of protein kinase C inhibitors on fibronectin induced beta gene transcription, protein synthesis and secretion in human monocytic cells. Immunology 1998; 95: 264-71.
25. [25] Mandi Y, Farkas G, Ocsovszky I, Nagy Z. Inhibition of tumour necrosis factor production and ICAM-1 expression by pentoxifylline - beneficial effects in sepsis syndrome. Res Exp Med 1995; 195: 297-307.
26. [26] Ockenhouse CF, Tegoshi T, Maeno Y, Benjamin C, Ho M, Kan KE, et al. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leucocyte adhesion molecule 1 and vascular adhesion molecule 1. J Exp Med 1992; 176: 1183-9.
27. [27] Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989; 341: 57-9.
28. [28] Auger MJ. Ross JA. The Biology of the Macrophage. In: Lewis CE, McGee J O'D, editors. The macrophage: the natural immune system. Oxford: IRL, 1992: 1-57.
29. [29] Goldring JPD, Nemaorani S. Antimalarial drugs modulate the expression of monocyte receptors. Int J Immunopharmacol 1999; 21: 559-607.
30. [30] Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193: 673-5.
31. [31] Freese JA, Ridl FC, Sharp BL, Markus MB. In vitro cultivation of Southern African strains of Plasmodium falciparum and gametocytogenesis. S Afr Med J 1988; 73: 720-2.
32. [32] Tamaoki J, Chiyotani, A, Yamauchi G, Takeuchi S, Takaziwa T. Ambroxol inhibits Na absorption by canine airway epithelial cells in culture. J Pharm Pharmacol 1991; 43: 841-3.
33. [33] Surrey ES, Halme J. Direct effects of medroxyprogesterone acetate, danazol and leuprolide acetate on endometrial stromal cell proliferation in vitro. Fertil Steril 1992; 58: 273-8.
34. [34] Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage Ia expression and interleukin-1 production. J Immunol 1982; 129: 1803-5.
35. [35] Ockenhouse CF, Chulay JD. Plasmodium falciparum sequestration: OKM5 antigen (CD36) mediates cytoadherence of parasitized erythrocytes to a myelomonocytic cell line. J Infect Dis 1988; 157: 584-8.
36. [36] Smith H, Nelson JA, Gahmberg CG, Crandall I, Sherman IW. Plasmodium falciparum: cytoadherence of malaria-infected erythrocytes to human brain capillary and umbilical vein endothelial cells - a comparative study of adhesive ligands. Exp Parasitol 1992; 75: 269-80.
37. [37] Waisman D, Vaneeden SF, Hogg JC, Solimano A, Massing B, Bondy GP. L-selectin expression on polymorphonuclear leukocytes and monocytes in premature infants - reduced expression after dexamethasone treatment for bronchopulmonary dysplasia. J Paediatr 1998; 132: 53-6.
38. [38] Niu XL, Yan XD, Guo ZG. Oxidized low density lipoprotein stimulate adhesion of monocytes to endothelial cells. Acta Pharmacol Sin 1997; 18: 59-62.
39. [39] Weill D, Wautier JL, Dosquet C, Wautier JP, Carreno MP, Boval B. Monocyte modulation of endothelial leukocyte adhesion molecules. J Lab Clin Med 1995; 125: 768-74.
40. [40] Martindale, The extra Pharmacopoeia. In: Reynolds JEF, editor. London: The Pharaceutical Press, 1993.
41. [41] Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, et al. Tumour necrosis factor and disease severity in children with falciparum malaria. New Engl J Med 1989; 320: 1586-91.
42. [42] Kern P, Hemmer CJ, Van Damme J, Grass HJ, Deitrich M. Elevated tumour necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989; 87: 139-43.
43. [43] Clark IA, Chaudhri G, Cowden WB. Roles of tumour necrosis factor in the illness and pathology of malaria. Trans R Soc Trop Med Hyg 1987; 83: 436-40.
44. [44] Woodruff AN, Dickinson CT. Use of dexamethasone in cerebral malaria. Br Med J 1968; 3: 31-2.
45. [45] Newton CRJC, Crawley J, Sowumni A, Waruiru C, Mwangi I, English M et al. Intra cranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997; 3: 219-26.
46. [46] Picot S, Peyron F, Vuillez JP, Polack B, Ambrose-Thomas P. Chloroquine inhibits tumour necrosis factor production by human macrophages in vitro. J Infect Dis 1991; 164: 830-4.
47. [47] Goldring JPD, Padayachee T, Ismail I. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil. Mem Inst Oswaldo Cruz 1999; 94: 667-74.